EZH2 and breast cancer: It has been well documented that DANCR was overexpressed and amplified in breast cancer, and knockdown of DANCR significantly inhibited cell proliferation and invasion in breast cancer through facilitating binding of EZH2 to the promoters of ABCG2 and CD44 genes14.